Stay updated on Nebulized Fentanyl in ILD Patients Clinical Trial
Sign up to get notified when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.

Latest updates to the Nebulized Fentanyl in ILD Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' was added and the prior notice (Revision: v3.4.1) removed, with the study content unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a funding/operating-status notice and the updated Revision: v3.4.1; removed the previous Revision: v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedThe glossary is now shown and several QA/metadata labels were updated: the caption 'Last Update Submitted that Met QC Criteria' is used instead of 'met', 'No FEAR Act Data' capitalization was adjusted, and the revision line shows 'Revision: v3.4.0'. The previous wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' was removed.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. This appears to be a minor version bump rather than substantive updates.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section added with Ontario as a study site. The HHS Vulnerability Disclosure and Ontario Locations sections were removed; page revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page shows a minor revision tag update from v3.2.0 to v3.3.2; there are no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nebulized Fentanyl in ILD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.